{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T08:10:20Z","timestamp":1756368620444,"version":"3.44.0"},"reference-count":31,"publisher":"BMJ","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ Case Reports"],"abstract":"<jats:p>The prognosis in amyloid light chain (AL)-amyloidosis and multiorgan involvement is poor, with a high-treatment-related mortality after high-dose melphalan and autologous stem cell transplantation (HDM\/SCT). Some patients, however, might benefit from the therapy. We report a case of cardiac AL-amyloidosis with multiorgan involvement where the progressive cardiomyopathy was halted after successful treatment with HDM\/SCT in 2001. The patient is in an excellent cardiac condition with a good quality of life, receiving treatment with angiotensinogen receptor blockers and a flexible diuretics regimen at follow-up after 10 years.<\/jats:p>","DOI":"10.1136\/bcr.03.2011.4007","type":"journal-article","created":{"date-parts":[[2011,8,18]],"date-time":"2011-08-18T10:04:05Z","timestamp":1313661845000},"page":"bcr0320114007","source":"Crossref","is-referenced-by-count":1,"title":["Ten-year follow-up after autologous stem cell transplantation of a patient with immunoglobulin light-chain (AL) amyloidosis with deposits in the heart, liver and gastrointestinal tract"],"prefix":"10.1136","volume":"2011","author":[{"given":"Marit","family":"Mejhert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Hast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benngt","family":"Sandstedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izabella","family":"Janczewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2011,8,18]]},"reference":[{"key":"2025082800522422000_2011.aug17_1.bcr0320114007.1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/11.supp9.53"},{"key":"2025082800522422000_2011.aug17_1.bcr0320114007.2","first-page":"45","article-title":"Primary systemic amyloidosis: clinical and laboratory features in 474 cases.","volume":"32","author":"Kyle","year":"1995","journal-title":"Semin Hematol"},{"key":"2025082800522422000_2011.aug17_1.bcr0320114007.3","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood.V79.7.1817.1817","article-title":"Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989.","volume":"79","author":"Kyle","year":"1992","journal-title":"Blood"},{"key":"2025082800522422000_2011.aug17_1.bcr0320114007.4","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705354"},{"key":"2025082800522422000_2011.aug17_1.bcr0320114007.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2007.09.014"},{"key":"2025082800522422000_2011.aug17_1.bcr0320114007.6","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1182\/blood.V87.7.3063.bloodjournal8773063","article-title":"High-dose melphalan and autologous bone marrow transplantation for systemic AL amyloidosis with cardiac involvement.","volume":"87","author":"Moreau","year":"1996","journal-title":"Blood"},{"key":"2025082800522422000_2011.aug17_1.bcr0320114007.7","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1182\/blood.V88.7.2801.bloodjournal8872801","article-title":"Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patients.","volume":"88","author":"Comenzo","year":"1996","journal-title":"Blood"},{"key":"2025082800522422000_2011.aug17_1.bcr0320114007.8","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00772.x"},{"key":"2025082800522422000_2011.aug17_1.bcr0320114007.9","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1182\/blood.V91.10.3662","article-title":"Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients.","volume":"91","author":"Comenzo","year":"1998","journal-title":"Blood"},{"key":"2025082800522422000_2011.aug17_1.bcr0320114007.10","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00813.x"},{"key":"2025082800522422000_2011.aug17_1.bcr0320114007.11","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.42.72"},{"key":"2025082800522422000_2011.aug17_1.bcr0320114007.12","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-005-0505-x"},{"key":"2025082800522422000_2011.aug17_1.bcr0320114007.13","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-140-2-200401200-00008"},{"key":"2025082800522422000_2011.aug17_1.bcr0320114007.14","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.12.4276"},{"key":"2025082800522422000_2011.aug17_1.bcr0320114007.15","doi-asserted-by":"publisher","DOI":"10.1080\/13506120701613984"},{"key":"2025082800522422000_2011.aug17_1.bcr0320114007.16","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0b013e328342b840"},{"key":"2025082800522422000_2011.aug17_1.bcr0320114007.17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-11-253237"},{"key":"2025082800522422000_2011.aug17_1.bcr0320114007.18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-294405"},{"key":"2025082800522422000_2011.aug17_1.bcr0320114007.19","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-032987"},{"key":"2025082800522422000_2011.aug17_1.bcr0320114007.20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-030544"},{"key":"2025082800522422000_2011.aug17_1.bcr0320114007.21","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-010-1062-6"},{"key":"2025082800522422000_2011.aug17_1.bcr0320114007.22","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.8220"},{"key":"2025082800522422000_2011.aug17_1.bcr0320114007.23","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11325"},{"key":"2025082800522422000_2011.aug17_1.bcr0320114007.24","doi-asserted-by":"publisher","DOI":"10.1080\/00365520410008105"},{"key":"2025082800522422000_2011.aug17_1.bcr0320114007.25","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702643"},{"key":"2025082800522422000_2011.aug17_1.bcr0320114007.26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-12-4192"},{"key":"2025082800522422000_2011.aug17_1.bcr0320114007.27","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-07-099481"},{"key":"2025082800522422000_2011.aug17_1.bcr0320114007.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2008.11.918"},{"key":"2025082800522422000_2011.aug17_1.bcr0320114007.29","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/13506120209114818","article-title":"AL amyloidosis treated with induction chemotherapy with VAD followed by high dose melphalan and autologous stem cell transplantation.","volume":"9","author":"Van Gameren","year":"2002","journal-title":"Amyloid"},{"key":"2025082800522422000_2011.aug17_1.bcr0320114007.30","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703200"},{"key":"2025082800522422000_2011.aug17_1.bcr0320114007.31","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.46.0142"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr.03.2011.4007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T07:52:35Z","timestamp":1756367555000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr.03.2011.4007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,18]]},"references-count":31,"alternative-id":["10.1136\/bcr.03.2011.4007"],"URL":"https:\/\/doi.org\/10.1136\/bcr.03.2011.4007","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2011,8,18]]}}}